His research and clinical interest include onco-nephrology (co-existing cancer and kidney disease), with specific focus on toxicities of cancer therapies and cancer treatment options in the setting of chronic kidney disease. He also has interest and expertise in the use of population-level healthcare administrative data for clinical research.